- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Peregrine Pharmaceuticals Inc+ Add to Watchlist
PPHM:US1.4700 USD 0.0100 0.68%
As of 17:20:00 ET on 03/04/2015.
Company Profile for Peregrine Pharmaceuticals Inc (PPHM)
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of novel therapeutics for cancer and a wide range of viral diseases.
Peregrine Pharmaceuticals Inc
Key Executives for Peregrine Pharmaceuticals Inc (PPHM)
|Steven W KingPresident/CEO||Paul J LytleChief Financial Officer|
|Mark R ZiebellVP/Secretary/General Counsel||Shelley P M FusseyVP:Intellectual Property|
|Joseph S ShanVP:Regulatory Affairs|